Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 2801–2850 of 76231
Gary R. Kohl, Group President, SGK Brand Solutions was appointed Chief Executive Officer of the Joint Venture and resigned as an executive officer of Matthews.
On April 30, 2025, Glen Van Treek provided notice of his retirement from the Company as President and Chief Operating Officer of Paramount Gold Nevada Corp. (the “Company”).
On April 30, 2025, Mr. Eric S. Musser, President and Chief Operating Officer, informed the Corning Incorporated (the “Company”) Board of Directors (the “Board of Directors”) that he will retire in mid-2025.
Michael A. Hug, the Company's current CFO, will step down from that role on the Transition Date and continue as an employee of a subsidiary of the Company until his previously announced retirement on June 9, 2025
Mr. Reiner also expects to resign from the Company's Board of Directors on such date.
the Company's current President and Chief Executive Officer, Andres Reiner, will be retiring from such offices effective as of Mr. Cotten's start date.
On April 25, 2025, Judd Merrill notified us that he intends to resign as our Chief Financial Officer effective on May 16, 2025
the Company has accepted the resignation of its Board member and Vice President of Operations, Mohammad Sadrolashrafi, as well as appointing Robert James Kane as a new director and Business Development Officer.
On April 29, 2025, Mark Jenkins, a Class II director of Carlyle Secured Lending, Inc. (the “Company”) and a Managing Director of The Carlyle Group, Inc. (“Carlyle”), informed the Company that he is resigning from the Board of Directors of the Company (the “Board”), effective April 29, 2025.
In connection with Ms. Treadway’s termination effective as of April 2, 2025 (the “Treadway Separation Date”), the Company and Ms. Treadway entered into a separation agreement effective as of May 1, 2025 (the “Treadway Separation Agreement”).
On April 25, 2025, Andrew Dahlem resigned from the Board of Directors of Syra Health Corp. (the “Company”) for personal reasons.
Mr. Terence Wise notified the Company of his intention to resign from his position as the Company’s Chief Executive Officer and as a member of the Company’s Board of Directors.
On April 29, 2025, Mark Jenkins, a Class II director of Carlyle Credit Solutions, Inc. (the “Company”) and a Managing Director of The Carlyle Group, Inc. (“Carlyle”), informed the Company that he is resigning from the Board of Directors of the Company (the “Board”), effective April 29, 2025.
Nancy Avila's term as a director ended on April 29, 2025.
On April 25, 2025, Simon M. Bates informed DMC Global Inc. ("DMC") of his decision to resign from the Board of Directors of DMC (the "Board") effective April 30, 2025
On April 28, 2025, Christopher Schell, Executive Vice President, Chief Commercial Officer, and General Manager of Sales, Marketing and Communications, notified Intel of his decision to resign, effective as of June 30, 2025, in order to pursue another career opportunity.
D. Adamczyk notified the Company that he intends to retire from the Company’s Board of Directors in connection with an announcement on April 23 rd that he will join Goldman Sachs as a Partner.
the role then held by Annie Bloomquist , Executive Vice President and Chief Innovation Officer was eliminated and she ceased serving in that role
Robert Willett advised the Company that he will retire as Chief Executive Officer (“CEO”) of the Company, effective June 27, 2025
the Company and its Executive Vice President and Chief Financial Officer, Neill P. Reynolds, have agreed that he will be departing the Company effective May 30, 2025.
Mr. Hadley, age 52, will succeed Don McGuire who will be stepping down from this role as of June 30, 2025, and will continue to serve as a corporate officer of the Company during a transition period through September 30, 2025.
On April 24, 2025, Laureen DeBuono notified the Board of Directors (“Board”) of Rani Therapeutics Holdings, Inc. (the “Company”) that she has decided to retire from the Board effective immediately.
On April 29, 2025, Timothy Dieffenbacher notified FrontView REIT, Inc. (the “Company”) of his decision to resign from his role as Chief Financial Officer, Treasurer, and Secretary of the Company, effective May 5, 2025.
On April 25, 2025, the Company and Steve Priest, the Company’s current Senior Vice President and Chief Financial Officer, determined that Mr. Priest will step down as Senior Vice President and Chief Financial Officer of the Company, effective May 11, 2025.
each of Evan Bayh, Jonathan Foster, James Glerum, Jr., Meredith Harper, Idalene Kesner, Kevin Kwilinski, Jill Rahman, Chaney Sheffield, Jr., Robert Steele, Stephen Sterrett and Peter Thomas resigned and ceased to be directors of Berry as of the Effective Time
each of Evan Bayh, Jonathan Foster, James Glerum, Jr., Meredith Harper, Idalene Kesner, Kevin Kwilinski, Jill Rahman, Chaney Sheffield, Jr., Robert Steele, Stephen Sterrett and Peter Thomas resigned and ceased to be directors of Berry as of the Effective Time
each of Evan Bayh, Jonathan Foster, James Glerum, Jr., Meredith Harper, Idalene Kesner, Kevin Kwilinski, Jill Rahman, Chaney Sheffield, Jr., Robert Steele, Stephen Sterrett and Peter Thomas resigned and ceased to be directors of Berry as of the Effective Time
each of Evan Bayh, Jonathan Foster, James Glerum, Jr., Meredith Harper, Idalene Kesner, Kevin Kwilinski, Jill Rahman, Chaney Sheffield, Jr., Robert Steele, Stephen Sterrett and Peter Thomas resigned and ceased to be directors of Berry as of the Effective Time
each of Evan Bayh, Jonathan Foster, James Glerum, Jr., Meredith Harper, Idalene Kesner, Kevin Kwilinski, Jill Rahman, Chaney Sheffield, Jr., Robert Steele, Stephen Sterrett and Peter Thomas resigned and ceased to be directors of Berry as of the Effective Time
each of Evan Bayh, Jonathan Foster, James Glerum, Jr., Meredith Harper, Idalene Kesner, Kevin Kwilinski, Jill Rahman, Chaney Sheffield, Jr., Robert Steele, Stephen Sterrett and Peter Thomas resigned and ceased to be directors of Berry as of the Effective Time
each of Evan Bayh, Jonathan Foster, James Glerum, Jr., Meredith Harper, Idalene Kesner, Kevin Kwilinski, Jill Rahman, Chaney Sheffield, Jr., Robert Steele, Stephen Sterrett and Peter Thomas resigned and ceased to be directors of Berry as of the Effective Time
each of Evan Bayh, Jonathan Foster, James Glerum, Jr., Meredith Harper, Idalene Kesner, Kevin Kwilinski, Jill Rahman, Chaney Sheffield, Jr., Robert Steele, Stephen Sterrett and Peter Thomas resigned and ceased to be directors of Berry as of the Effective Time
each of Evan Bayh, Jonathan Foster, James Glerum, Jr., Meredith Harper, Idalene Kesner, Kevin Kwilinski, Jill Rahman, Chaney Sheffield, Jr., Robert Steele, Stephen Sterrett and Peter Thomas resigned and ceased to be directors of Berry as of the Effective Time
each of Evan Bayh, Jonathan Foster, James Glerum, Jr., Meredith Harper, Idalene Kesner, Kevin Kwilinski, Jill Rahman, Chaney Sheffield, Jr., Robert Steele, Stephen Sterrett and Peter Thomas resigned and ceased to be directors of Berry as of the Effective Time
each of Evan Bayh, Jonathan Foster, James Glerum, Jr., Meredith Harper, Idalene Kesner, Kevin Kwilinski, Jill Rahman, Chaney Sheffield, Jr., Robert Steele, Stephen Sterrett and Peter Thomas resigned and ceased to be directors of Berry as of the Effective Time
Arun Nayar, Andrea Bertone and David Szczupak resigned from the Board.
Arun Nayar, Andrea Bertone and David Szczupak resigned from the Board.
Arun Nayar, Andrea Bertone and David Szczupak resigned from the Board.
On April 28, 2025, Mr. Christoph Schell informed Mobileye Global Inc. (the “Company”) of his resignation from the board of directors (the “Board”), to be effective as of June 30, 2025
On April 29, 2025 Merdad Parsey, M.D., Ph.D., current member of the board of directors (the “Board”) of Sagimet Biosciences Inc. (the “Company”), notified the Board that he will not stand for re-election at the Company’s 2025 Annual Meeting of Stockholders (the “Annual Meeting”), currently scheduled to be held on June 9, 2025.
On April 29, 2025, Mr. J. Markham Green elected not to stand for re-election at the Hilltop Holdings Inc. (the “Company”) 2025 Annual Meeting of Stockholders to be held on July 24, 2025 (the “Annual Meeting”).
On April 25, 2025, Brigitte Muehlmann, PhD and CPA, informed CreditRiskMonitor.com, Inc. (the “Company”) that she does not intend to stand for re-election to its Board of Directors.
Sahil Kirpekar’s employment as Chief Business Officer of atai Life Sciences US, Inc. (“atai US”) and its affiliates, including atai Life Sciences N.V. (the “Company”), terminated effective April 2, 2025.
John F. Woods, Vice Chair and Chief Financial Officer, notified the Company on April 24, 2025 of his decision to depart from the Company to accept another opportunity.
On April 30, 2025, Randall D. Lehner, the General Counsel of Power Solutions International, Inc. (the “Company” or “PSI”), and the Company have mutually agreed that it is in the best interest of the parties to terminate the employment agreement
Thomas Emery has resigned from his role as Secretary of the Company, effective April 28, 2025.
Thomas Emery has resigned from his role as Secretary of the Company, effective April 28, 2025.
On April 30, 2025, the Board of Directors of Society Pass Incorporated (the “Company”) accepted the resignation of Mr. Rokas Sidlauskas (“Mr. Sidlauskas”) as the Group Chief Marketing Officer (“CMO”).
On April 24, 2025, Ms. Qingqing Wang, the Board Secretary of the Company, notified the Board that she was resigning from the Board Secretary, effective as of April 24, 2025.
Michael Crawford announced he intends to resign as the Company’s President, Chief Executive Officer, and Chairman of the Board of Directors, effective May 18, 2025
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.